Proteinase-Activated Receptor 4 (PAR4) Activation Triggers Cell Membrane Blebbing through RhoA and β-arrestin
C. M. Vanderboor, P. E. Thibeault, K. C. Nixon, R. Gros, J. M. Kramer, R. Ramachandran
Abstract
Proteinase-Activated Receptors (PARs) are a four-member family of G-protein coupled receptors that are activated via proteolysis. PAR4 is a member of this family that is cleaved and activated by serine proteinases such as thrombin, trypsin and cathepsin-G. PAR4 is expressed in a variety of tissues and cell types including platelets, vascular smooth muscle cells and neuronal cells. In studying PAR4 signalling and trafficking, we observed dynamic changes in the cell membrane with spherical membrane protrusions that resemble plasma membrane blebbing. Since non-apoptotic membrane blebbing is now recognized as an important regulator of cell migration, cancer cell invasion, and vesicular content release we sought to elucidate the signalling pathway downstream of PAR4 activation that leads to such events. Using a combination of pharmacological inhibition and CRISPR/Cas9-mediated gene-editing approaches we establish that PAR4-dependent membrane blebbing occurs independently of the Gq/11 and Gi signalling pathways and is dependent on signalling via the {beta}-arrestin-1/-2 and RhoA signalling pathways. In order to gain a more comprehensive understanding of {beta}-arrestin-mediated signalling downstream of PAR4 and to guide future studies, we undertook RNA-seq analysis of PAR4 activated genes in control cells and in cells lacking {beta}-arrestin-1/-2. A list of differentially expressed genes was generated followed by Gene Ontology (GO) and enrichment analysis, revealing PAR4 regulation of genes involved in processes including blood coagulation and circulation, cell-cell adhesion, sensory perception and neuron-neuron synaptic transmission-terms that relate back to known functions of PAR4 and are consistent with our finding of membrane blebbing triggered by PAR4 activation. Together these studies provide further mechanistic insight into PAR4 regulation of cellular function.\n\nSignificance StatementWe find that the thrombin receptor PAR4 triggers cell membrane blebbing in a RhoA- and {beta}-arrestin-dependent manner. In addition to identifying novel cellular responses mediated by PAR4, these data provide further evidence for biased signaling in PAR4 since membrane blebbing was dependent on some, but not all, signaling pathways activated by PAR4. Finally through CRISPR/Cas9-mediated targeting and RNA-seq analysis we catalogue here PAR4-dependent transcription that is dependent on {beta}-arrestin.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Molecular Basis for G-protein-Coupled Receptor (GPCR) Activation and Biased Signalling at the Platelet Thrombin Receptor Proteinase Activated Receptor-4 (PAR4)
P. Thibeault, J. C. LeSarge, … R. Ramachandran·bioRxiv·Sep 4, 2019
- Complement factor C4a does not activate protease activated receptor 1 (PAR1) or PAR4 on human platelets.
X. Han, M. de la Fuente, M. T. Nieman·bioRxiv·Jun 1, 2020
- Piezo1 activation attenuates thrombin-induced blebbing in breast cancer cells
P. O'Callaghan, A. Engberg, … J. Kreuger·bioRxiv·Apr 30, 2020
- Signaling bias of the protease-activated receptor-1 is dictated by distinct GRK5 and β-arrestin-2 determinants
Monica L. Gonzalez Ramirez, Lennis B. Orduña-Castillo, … JoAnn Trejo·Cell ReportsPeer-reviewed·Mar 1, 2026
- Activated protein C promotes beta-arrestin-2- and c-Src-dependent caveolin-1 (Cav1) phosphorylation and alters Cav1 association with PAR1 and GRK5
Huaping Qin, Lennis B. Orduña-Castillo, … JoAnn Trejo·bioRxiv·Nov 2, 2025
- Lack of canonical PAR4 activation is associated with reduced arterial and venous thrombosis in mice.
Robert Hugh Lee, Jenna R. Severa, … Silvio Antoniak·bioRxiv·Jul 23, 2026